Annual Short Term Debt
$41.12 M
+$40.63 M+8274.54%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual short term debt is $41.12 million, with the most recent change of +$40.63 million (+8274.54%) on December 31, 2023.
- During the last 3 years, EIGR annual short term debt has risen by +$40.54 million (+6965.12%).
- EIGR annual short term debt is now at all-time high.
Performance
EIGR Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$41.12 M
+$40.91 M+19958.05%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly short term debt is $41.12 million, with the most recent change of +$40.91 million (+19958.05%) on December 31, 2023.
- Over the past year, EIGR quarterly short term debt has increased by +$40.63 million (+8274.54%).
- EIGR quarterly short term debt is now at all-time high.
Performance
EIGR Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
EIGR Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8274.5% | +8274.5% |
| 3 y3 years | +6965.1% | +6965.1% |
| 5 y5 years | +100.0% | +100.0% |
EIGR Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +8274.5% | at high | >+9999.0% |
| 5 y | 5-year | at high | +8274.5% | at high | >+9999.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Eiger BioPharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $41.12 M(+8274.5%) | $41.12 M(>+9900.0%) |
| Sep 2023 | - | $205.00 K(-36.1%) |
| Jun 2023 | - | $321.00 K(-26.2%) |
| Mar 2023 | - | $435.00 K(-11.4%) |
| Dec 2022 | $491.00 K(-94.2%) | $491.00 K(+77.3%) |
| Sep 2022 | - | $277.00 K(-36.5%) |
| Jun 2022 | - | $436.00 K(-96.7%) |
| Mar 2022 | - | $13.14 M(+55.7%) |
| Dec 2021 | $8.44 M(+1349.7%) | $8.44 M(+129.3%) |
| Sep 2021 | - | $3.68 M(+523.7%) |
| Jun 2021 | - | $590.00 K(-1.5%) |
| Mar 2021 | - | $599.00 K(+2.9%) |
| Dec 2020 | $582.00 K | $582.00 K(-90.8%) |
| Sep 2020 | - | $6.35 M(+65.7%) |
| Jun 2020 | - | $3.83 M(+595.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $551.00 K(+3.2%) |
| Dec 2019 | $534.00 K(>+9900.0%) | $534.00 K(+14.6%) |
| Sep 2019 | - | $466.00 K(+3.1%) |
| Jun 2019 | - | $452.00 K(+3.0%) |
| Mar 2019 | - | $439.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $6.57 M(+102.5%) |
| Jun 2018 | - | $3.24 M(-0.3%) |
| Mar 2018 | - | $3.25 M(+62.5%) |
| Dec 2017 | $2.00 M(>+9900.0%) | $2.00 M(-81.1%) |
| Jun 2015 | - | $10.59 M(+533.6%) |
| Mar 2015 | - | $1.67 M(>+9900.0%) |
| Dec 2014 | $1000.00(-99.9%) | $1000.00(-99.9%) |
| Dec 2013 | $1.04 M(-91.5%) | $1.04 M |
| Dec 2011 | $12.35 M | - |
FAQ
- What is Eiger BioPharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual short term debt year-on-year change?
- What is Eiger BioPharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly short term debt year-on-year change?
What is Eiger BioPharmaceuticals annual short term debt?
The current annual short term debt of EIGR is $41.12 M
What is the all time high annual short term debt for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual short term debt is $41.12 M
What is Eiger BioPharmaceuticals annual short term debt year-on-year change?
Over the past year, EIGR annual short term debt has changed by +$40.63 M (+8274.54%)
What is Eiger BioPharmaceuticals quarterly short term debt?
The current quarterly short term debt of EIGR is $41.12 M
What is the all time high quarterly short term debt for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly short term debt is $41.12 M
What is Eiger BioPharmaceuticals quarterly short term debt year-on-year change?
Over the past year, EIGR quarterly short term debt has changed by +$40.63 M (+8274.54%)